TELA Bio, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: TELA Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
TELA Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $1.04M, a 5.26% decline year-over-year.
TELA Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $4.3M, a 14% decline year-over-year.
TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4.36M, a 13.3% decline from 2023.
TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.03M, a 26.1% increase from 2022.
TELA Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.99M, a 8.96% increase from 2021.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Annual (USD)

Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2024	$4.36M	-$670K	-13.3%	Jan 1, 2024	Dec 31, 2024	10-K	2025-03-21
2023	$5.03M	+$1.04M	+26.1%	Jan 1, 2023	Dec 31, 2023	10-K	2025-03-21
2022	$3.99M	+$328K	+8.96%	Jan 1, 2022	Dec 31, 2022	10-K	2025-03-21
2021	$3.66M	+$1.6M	+77.9%	Jan 1, 2021	Dec 31, 2021	10-K	2024-03-22
2020	$2.06M	+$1.6M	+350%	Jan 1, 2020	Dec 31, 2020	10-K	2023-03-23
2019	$457K	+$241K	+112%	Jan 1, 2019	Dec 31, 2019	10-K	2022-03-23
2018	$216K	+$19K	+9.65%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-25
2017	$197K			Jan 1, 2017	Dec 31, 2017	10-K	2020-03-30

Showing 1 to 8 of 8 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.